Supplemental Figure S3 from MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

Autor:	Earl F. Albone, Luigi Grasso, Toshimitsu Uenaka, Frank Fang, Keiji Furuuchi, Megan Kuc, Danielle Fernando, Shawn Fernando, Katherine A. Rybinski, Christopher J. Maddage, Arielle C. Verdi, Andrew Z. Milinichik, Utpal Majumder, Keigo Tanaka, Jing Li, Xin Cheng
Rok vydání:	2023
DOI:	10.1158/1535-7163.22504753
Popis:	Analyses of faletuzumab and amatuximab ADCs
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f950144be3df06a83a14f215b297b7 https://doi.org/10.1158/1535-7163.22504753 Zobrazit plný text záznamu